Although glucagon signaling inhibition clearly shows various metabolic benefits for diabetes treatment in animal (mostly murine) models, hyperglucagonemia and α cell hyperplasia cast doubt on the safety of that approach [8]-[14]. Here, GCG is linked to diabetes mellitus.